MAYO CLINIC

🇺🇸United States

Country: 🇺🇸United States

Ownership: Subsidiary

Established: 1889-01-01

Employees: 10K

Market Cap: -

Website: http://www.mayoclinic.org

Clinical Trials

MR-Guided Laser Ablation of Prostate Bed Recurrences

Not Applicable

Withdrawn

Conditions: Prostate Tumors

Interventions: Procedure: MR-Guided Laser Ablation

First Posted Date: 2012-12-06

Last Posted Date: 2014-04-10

Lead Sponsor: Mayo Clinic

Registration Number: NCT01743638

Locations: 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

Tailored Antiplatelet Therapy Following PCI

Phase 4

Completed

Conditions: Coronary Artery Disease
Stenosis
Acute Coronary Syndrome

Interventions: Drug: Clopidogrel
Drug: Ticagrelor

First Posted Date: 2012-12-05

Last Posted Date: 2021-11-09

Lead Sponsor: Mayo Clinic

Target Recruit Count: 5276

Registration Number: NCT01742117

Locations: 🇺🇸
Loyola University Medical Center, Maywood, Illinois, United States
🇺🇸
The Feinstein Institute for Medical Research, Manhasset, New York, United States
🇨🇦
Humber River Hospital, Toronto, Ontario, Canada

and more 38 locations

Effects of Aging and Aerobic Exercise Training on Brain Glucose Metabolism

Not Applicable

Completed

Conditions: Dementia

Interventions: Behavioral: High intensity aerobic training
Behavioral: Sedentary Control

First Posted Date: 2012-11-30

Last Posted Date: 2021-08-30

Lead Sponsor: Mayo Clinic

Target Recruit Count: 27

Registration Number: NCT01738568

Locations: 🇺🇸
Mayo Clinic in Rochester, Rochester, Minnesota, United States

Sirolimus and Auranofin in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer or Small Cell Lung Cancer

Phase 1

Completed

Conditions: Lung Adenocarcinoma
Recurrent Small Cell Lung Carcinoma
Stage IV Non-Small Cell Lung Cancer
Squamous Cell Lung Carcinoma
Stage IIIA Non-Small Cell Lung Cancer
Recurrent Non-Small Cell Lung Carcinoma
Extensive Stage Small Cell Lung Carcinoma
Stage IIIB Non-Small Cell Lung Cancer

Interventions: Drug: Auranofin
Drug: Sirolimus
Other: Laboratory Biomarker Analysis
Other: Pharmacological Study

First Posted Date: 2012-11-29

Last Posted Date: 2024-03-25

Lead Sponsor: Mayo Clinic

Target Recruit Count: 29

Registration Number: NCT01737502

Locations: 🇺🇸
Mayo Clinic, Jacksonville, Florida, United States
🇺🇸
Mayo Clinic in Arizona, Scottsdale, Arizona, United States

Title: "Development and Implementation of Innovative Auditory Training Methods and Verification of These Training Methods"

Not Applicable

Completed

Conditions: Cochlear Implant

Interventions: Behavioral: LACE
Behavioral: NOOK

First Posted Date: 2012-11-29

Last Posted Date: 2017-09-08

Lead Sponsor: Mayo Clinic

Target Recruit Count: 17

Registration Number: NCT01737489

Locations: 🇺🇸
Mayo Clinic in Rochester, Rochester, Minnesota, United States

The Effect of Meditation and Massage Therapy for Breast Cancer Patients Undergoing Tissue Reconstruction

Not Applicable

Completed

Conditions: Breast Cancer

Interventions: Procedure: Massage
Procedure: Massage combined with meditation

First Posted Date: 2012-11-29

Last Posted Date: 2015-04-07

Lead Sponsor: Mayo Clinic

Target Recruit Count: 40

Registration Number: NCT01736605

Locations: 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

Influence of Medication Taste on Pediatric Prescribers' Prescribing Habits

Phase 1

Completed

Conditions: Healthy

Interventions: Drug: Taste Test

First Posted Date: 2012-11-28

Last Posted Date: 2013-10-21

Lead Sponsor: Mayo Clinic

Target Recruit Count: 50

Registration Number: NCT01734759

Locations: 🇺🇸
Mayo Clinic in Rochester, Rochester, Minnesota, United States

Modulation of Esophageal Inflammation in Barrett's Esophagus by Omega-3 Fatty Acids

Phase 4

Completed

Conditions: Barrett's Esophagus
Obesity

Interventions: Drug: Placebo
Drug: Omega-3 polyunsaturated fatty acids

First Posted Date: 2012-11-26

Last Posted Date: 2022-01-11

Lead Sponsor: Mayo Clinic

Target Recruit Count: 60

Registration Number: NCT01733147

Locations: 🇺🇸
Mayo Clinic in Rochester, Rochester, Minnesota, United States

Ruxolitinib Phosphate and Danazol in Treating Anemia in Patients With Myelofibrosis

Phase 2

Completed

Conditions: Anemia
Primary Myelofibrosis
Secondary Myelofibrosis

Interventions: Drug: ruxolitinib phosphate
Drug: danazol
Other: quality-of-life assessment
Other: questionnaire administration

First Posted Date: 2012-11-22

Last Posted Date: 2017-10-18

Lead Sponsor: Mayo Clinic

Target Recruit Count: 14

Registration Number: NCT01732445

Locations: 🇺🇸
Mayo Clinic in Arizona, Scottsdale, Arizona, United States
🇺🇸
Tisch Cancer Center, New York, New York, United States

Dietary Interventions in Prediabetes

Not Applicable

Completed

Conditions: Liver Fat
Impaired Fasting Glucose
Pre Diabetes

Interventions: Dietary Supplement: Dietary intervention

First Posted Date: 2012-11-20

Last Posted Date: 2015-07-29

Lead Sponsor: Mayo Clinic

Target Recruit Count: 48

Registration Number: NCT01729078

Locations: 🇺🇸
Mayo clinic, Rochester, Minnesota, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy